Literature DB >> 24929484

Volatile organic compounds in bile can diagnose malignant biliary strictures in the setting of pancreatic cancer: a preliminary observation.

Udayakumar Navaneethan1, Mansour A Parsi1, Norma G Gutierrez1, Amit Bhatt1, Preethi G K Venkatesh1, Dennisdhilak Lourdusamy1, David Grove2, Jeffrey P Hammel1, Sunguk Jang1, Madhusudhan R Sanaka1, Tyler Stevens1, John J Vargo1, Raed A Dweik2.   

Abstract

BACKGROUND: Ascertaining the nature of biliary strictures is challenging. The role of volatile organic compounds (VOCs) in bile in determining the cause of biliary strictures is not known.
OBJECTIVE: To identify potential VOCs in the headspaces (gas above the sample) of bile in patients with malignant biliary strictures from pancreatic cancer.
DESIGN: Prospective cross-sectional study.
SETTING: Referral center. PATIENTS: Prospective study in which bile was aspirated in 96 patients undergoing ERCP for benign and malignant conditions. MAIN OUTCOME MEASUREMENTS: Selected ion flow tube mass spectrometry (VOICE200R SIFT-MS instrument; Syft Technologies Ltd, Christchurch, New Zealand) was used to analyze the headspace and to build a predictive model for pancreatic cancer.
RESULTS: The headspaces from 96 bile samples were analyzed, including 24 from patients with pancreatic cancer and 72 from patients with benign biliary conditions. The concentrations of 6 compounds (acetaldehyde, acetone, benzene, carbon disulfide, pentane, and trimethylamine [TMA]) were increased in patients with pancreatic cancer compared with controls (P < .05). By using receiver-operating characteristic curve analysis, we developed a model for the diagnosis of pancreatic cancer based on the levels of TMA, acetone, isoprene, dimethyl sulfide, and acetaldehyde. The model [10.94 + 1.8229* log (acetaldehyde) + 0.7600* log (acetone) - 1.1746* log (dimethyl sulfide) + 1.0901* log (isoprene) - 2.1401 * log (trimethylamine) ≥ 10] identified the patients with pancreatic cancer (area under the curve = 0.85), with 83.3% sensitivity and 81.9% specificity. LIMITATIONS: Sample size.
CONCLUSIONS: The measurement of biliary fluid VOCs may help to distinguish malignant from benign biliary strictures. Further studies are warranted to validate these observations. (Clinical Trial Registration Number NCT01565460.).
Copyright © 2014 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24929484     DOI: 10.1016/j.gie.2014.04.016

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  16 in total

Review 1.  Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures.

Authors:  Vennisvasanth Lourdusamy; Benjamin Tharian; Udayakumar Navaneethan
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

2.  Volatile Organic Compounds in Urine for Noninvasive Diagnosis of Malignant Biliary Strictures: A Pilot Study.

Authors:  Udayakumar Navaneethan; Mansour A Parsi; Dennisdhilak Lourdusamy; David Grove; Madhusudhan R Sanaka; Jeffrey P Hammel; John J Vargo; Raed A Dweik
Journal:  Dig Dis Sci       Date:  2015-02-24       Impact factor: 3.199

3.  Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer.

Authors:  Samuel O Antwi; Elizabeth C Eckert; Corinna V Sabaque; Emma R Leof; Kieran M Hawthorne; William R Bamlet; Kari G Chaffee; Ann L Oberg; Gloria M Petersen
Journal:  Cancer Causes Control       Date:  2015-08-21       Impact factor: 2.506

Review 4.  Role of endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures: What's new?

Authors:  Rosa Ferreira; Rui Loureiro; Nuno Nunes; António Alberto Santos; Rui Maio; Marília Cravo; Maria Antónia Duarte
Journal:  World J Gastrointest Endosc       Date:  2016-02-25

Review 5.  Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis.

Authors:  Udayakumar Navaneethan; Basile Njei; Vennisvasanth Lourdusamy; Rajesh Konjeti; John J Vargo; Mansour A Parsi
Journal:  Gastrointest Endosc       Date:  2014-11-01       Impact factor: 9.427

6.  Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study.

Authors:  Udayakumar Navaneethan; Mansour A Parsi; Vennisvasanth Lourdusamy; Amit Bhatt; Norma G Gutierrez; David Grove; Madhusudhan R Sanaka; Jeffrey P Hammel; Tyler Stevens; John J Vargo; Raed A Dweik
Journal:  Gastrointest Endosc       Date:  2014-12-12       Impact factor: 9.427

Review 7.  Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.

Authors:  Fang Bao; Jiayue Liu; Haiyang Chen; Lu Miao; Zhaochao Xu; Guixin Zhang
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

Review 8.  Biliary strictures: diagnostic considerations and approach.

Authors:  Ajaypal Singh; Andres Gelrud; Banke Agarwal
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-10-28

9.  Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study.

Authors:  Udayakumar Navaneethan; Vennisvasanth Lourdusamy; Preethi Gk Venkatesh; Belinda Willard; Madhusudhan R Sanaka; Mansour A Parsi
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-10-09

10.  Research protocol for a diagnostic study of non-invasive exhaled breath analysis for the prediction of oesophago-gastric cancer.

Authors:  Sheraz R Markar; Jesper Lagergren; George B Hanna
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.